The Artificial Intelligence in Drug Discovery Industry, valued at USD 1.42 billion in 2023, is projected to grow at a remarkable Compound Annual Growth Rate (CAGR) of 29.7% from 2024 to 2031, reaching an estimated USD 11.37 billion by 2031. This exponential growth is fueled by advancements in AI technology, increasing demand for efficient drug discovery processes, and the rising incidence...